EFFICACY AND SAFETY OF NICORANDIL IN ACUTE CORONARY SYNDROME: A META-ANALYSIS-Reference-Cited by-同舟云学术

EFFICACY AND SAFETY OF NICORANDIL IN ACUTE CORONARY SYNDROME: A META-ANALYSIS

Published:2023-04-06 Issue: Volume: Page:
ISSN:
Container-title:
language:
Short-container-title:

Author:

Dani Avichal,Raithatha Shubh,Desai Dev^ORCID

Abstract

AbstractBackgroundNicorandil acts as a potassium channel opener, however its cardio protective benefit is still uncertain. This meta-analysis was conducted with the objective of evaluating the efficacy of nicorandil in improving cardiovascular outcomes in acute coronary syndrome.Main BodyA total of 24 RCTs with 1640 patients in the nicorandil group and 1592 patients in the control group were identified following PRISMA guidelines till November 2019 and were matched for inclusion and exclusion criteria. The following search strings and MESH terms were used: “nicorandil”, “ACS”, “MACE”. Following this, nicorandil was evaluated for its efficacy and safety outcomes. RevMan 5.3 was used for appropriate statistical tests. Fixed and Random Effect Model Test were used and p<0.05 was considered statistically significant.ResultsAdministration of nicorandil was found to be associated with a significant decrease in MACE (RR = 0.686, 95% CI = 0.509-0.925, p=0.013), no-reflow phenomenon (RR =0.395, 95% CI = 0.266-0.588, p<0.001) and worsening of HF (RR =0.441, 95% CI = 0.221-0.882, p=0.021). It was also associated with significant improvement in LVEF (SMD= 0.637, 95% CI= 0.0972 to 1.177, p=0.021) and significant lowering of cTFC (SMD= -0.216, 95% CI= -0.428 to -0.0041, p=0.046)ConclusionsNicorandil does indeed exert a cardio protective effect by improving cardiovascular outcomes. There is a significant decrease in occurrences of MACE and worsening of HF. There is also significant improvement in LVEF.

Publisher

Cold Spring Harbor Laboratory

Reference23 articles.

1. Ju Han Kim MHJ , Kyung Ho Yun , Kye Hun Kim , Dong Koo Kang , Seo Na Hong , Sang Yup Lim , Sang Hyun Lee , Yun Sang Lee , Young Joon Hong , Hyung Wook Park , Weon Kim , Young Keun Ahn , Jeong Gwang Cho , Jong Chun Park , Jung Chaee Kang . Myocardial protective effects of nicorandil during percutaneous coronary intervention in patients with unstable angina 2005 [Available from: https://pubmed.ncbi.nlm.nih.gov/15731536/.

2. Yusuke Kawai KH , Hiromi Matsubara , Kazuhiro Dan , Satoshi Akagi , Katsumasa Miyaji , Mitsuru Munemasa , Yoshihisa Fujimoto , Kengo F Kusano , Tohru Ohe . Intravenous administration of nicorandil immediately before percutaneous coronary intervention can prevent slow coronary flow phenomenon 2009 [Available from: https://pubmed.ncbi.nlm.nih.gov/19276198/.

3. Hirotsugu Ono TO , Hiroshi Ishizaka , Hiroyuki Hanada , Takaatsu Kamada , Hiroyuki Onodera , Norio Fujita , Shingo Sasaki , Toshiro Matsunaga , Ken Okumura ,. Nicorandil improves cardiac function and clinical outcome in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: role of inhibitory effect on reactive oxygen species formation 2004 [Available from: https://pubmed.ncbi.nlm.nih.gov/15459610/.

4. Masaaki Murakami KI , Shozo Kusachi , Kazuyoshi Hina , Minoru Hirota , Satoshi Hirohata , Shigeshi Kamikawa , Mutsuko Sangawa , Keizo Yamamoto , Yasushi Shiratori ,. Nicorandil reduces the incidence of minor cardiac marker elevation after coronary stenting 2006 [Available from: https://pubmed.ncbi.nlm.nih.gov/16337497/.

5. Satoshi Ota HN , Masaki Takeuchi , Kazuki Nakajima , Tomoaki Nakamura , Shinya Okamoto , Morimichi Setsuda , Katsutoshi Makino , Tetsu Yamakado , Takeshi Nakano ,. Impact of nicorandil to prevent reperfusion injury in patients with acute myocardial infarction: Sigmart Multicenter Angioplasty Revascularization Trial (SMART) 2006 [Available from: https://pubmed.ncbi.nlm.nih.gov/16936418/.